Regulations.gov document
FDA Updates on Possible Mitigation Strategies to Reduce the Risk of Nitrosamine Drug…
Other · FDA-2020-D-1530 · posted Nov 24, 2021
Key facts
| Document ID | FDA-2020-D-1530-0022 |
|---|---|
| Title | FDA Updates on Possible Mitigation Strategies to Reduce the Risk of Nitrosamine Drug Substance-Related Impurities in Drug Products |
| Document type | Other |
| Subtype | Additional Information |
| Agency | FDA |
| Docket | FDA-2020-D-1530 |
| Posted | Nov 24, 2021 |
| Comment period opens | Nov 24, 2021 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: